Dmitriy V. Gorokhov
Research Subjects
Research Interests
Dmitriy V. Gorokhov has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- A. E. Tsygankov
442 Military Clinical Hospital
2 shared publications - Elena Efimovna Petryaykina
Pirogov Russian National Research Medical University
2 shared publications - Ella V. Kumirova
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia; Morozovskaya Children’s Clinical Hospital of the Moscow City Healthcare Department
2 shared publications - Gennady Egorovich Chmutin
FSAEI HE Peoples Friendship University of Russia, 6 Miklukho-Maklaya str., Moscow, 117198, Russia
2 shared publications - Matvey Igorevich Livshits
Morozovskaya Children’s Clinical Hospital of the Moscow City Healthcare Department
2 shared publications - Valerii V. Gorev
Morozovskaya Children’s Clinical Hospital
2 shared publications
Latest Publications
- Open Access
- 12 August 2026
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 13 (2) , 54-64
Pediatric neurosurgical management of central nervous system tumors. A multidisciplinary hospital experience
Surgical treatment of central nervous system (CNS) tumors in children presents a complex medical and social challenge, driven not only by the relatively low prevalence of this pathology in pediatric practice but also by the significant heterogeneity of the disease, owing to the variability of patient age, tumor location, and histopathological structure. Despite these challenges, recent decades have seen progress in improving overall survival in children with CNS tumors, driven by the introduction of a multidisciplinary, personalized approach into clinical practice, based on modern therapeutic protocols and integrating the efforts of specialists from various fields. The introduction of molecular genetic tumor profiling methods has become particularly important in improving neuro-oncological care. The introduction of histological and molecular characteristics has become an integral diagnostic standard, allowing not only to establish a diagnosis, prognosis, and treatment strategy, but also to identify targets for targeted therapy. We present an analysis of surgical interventions in children with CNS tumors at a multidisciplinary hospital in Moscow. Interdisciplinary collaboration among neurosurgeons, oncologists, neurologists, radiologists, pathologists, and other related specialists plays a key role in achieving optimal treatment outcomes and improving patients’ quality of life. The study included 417 children who underwent surgery for CNS tumors at the Morozov Children’s City Clinical Hospital of the Department of Health of Moscow. The analysis included tumor resection volumes according to the Gnekow classification, CSF shunt procedures, complications, tumor location, histomolecular variants, overall survival, and mortality in this cohort of patients.
- 12 August 2026
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 13 (2) , 54-64
Open AccessPediatric neurosurgical management of central nervous system tumors. A multidisciplinary hospital experience
Surgical treatment of central nervous system (CNS) tumors in children presents a complex medical and social challenge, driven not only by the relatively low prevalence of this pathology in pediatric practice but also by the significant heterogeneity of the disease, owing to the variability of patient age, tumor location, and histopathological structure. Despite these challenges, recent decades have seen progress in improving overall survival in children with CNS tumors, driven by the introduction of a multidisciplinary, personalized approach into clinical practice, based on modern therapeutic protocols and integrating the efforts of specialists from various fields. The introduction of molecular genetic tumor profiling methods has become particularly important in improving neuro-oncological care. The introduction of histological and molecular characteristics has become an integral diagnostic standard, allowing not only to establish a diagnosis, prognosis, and treatment strategy, but also to identify targets for targeted therapy. We present an analysis of surgical interventions in children with CNS tumors at a multidisciplinary hospital in Moscow. Interdisciplinary collaboration among neurosurgeons, oncologists, neurologists, radiologists, pathologists, and other related specialists plays a key role in achieving optimal treatment outcomes and improving patients’ quality of life. The study included 417 children who underwent surgery for CNS tumors at the Morozov Children’s City Clinical Hospital of the Department of Health of Moscow. The analysis included tumor resection volumes according to the Gnekow classification, CSF shunt procedures, complications, tumor location, histomolecular variants, overall survival, and mortality in this cohort of patients.
- Open Access
- 23 July 2026
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 23 (3) , 341-350
Moderately Differentiated Adenocarcinoma of the Transverse Colon in a Child with Klippel – Trenaunay Syndrome: Case Report
Background. Klippel – Trenone syndrome (KTS) is a rare genetic disease that occurs with a frequency of 1 per 100,000 people and is characterized by a typical triad of symptoms: malformation of the capillary network (like a “wine stain”), hypertrophy of soft tissues and bones, and venous malformations of the extremities. Adenocarcinoma is a malignant formation of the glandular epithelium. This disease is extremely rare in children (about 1 case per 1 million people under the age of 20 years annually) due to its large regenerative potential and the absence of comorbid conditions that accumulate with age. In the article, we presented a case demonstrating a combination of these rare and severe diseases in a child. Case Report . We present a case report of the manifestation of adenocarcinoma of the transverse colon with the development of an acute intestinal obstruction clinic in a child with KTS. Conclusion . This case report demonstrates the combination of KTS and moderately malignant transverse colon adenocarcinoma in a child. This case is unique and valuable for clinical practice, emphasizing the need for thorough examination of patients with KTS due to the risk of cancer due to mutations in the PIK3CA oncogene. The combination of KTS with aggressive carcinoma leads to the development of complex comorbid pathology. The mutual aggravation of these diseases critically limits the possibilities of therapeutic correction and, as a result, dramatically reduces the expected survival rate of such patients.
- 23 July 2026
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 23 (3) , 341-350
Open AccessModerately Differentiated Adenocarcinoma of the Transverse Colon in a Child with Klippel – Trenaunay Syndrome: Case Report
Background. Klippel – Trenone syndrome (KTS) is a rare genetic disease that occurs with a frequency of 1 per 100,000 people and is characterized by a typical triad of symptoms: malformation of the capillary network (like a “wine stain”), hypertrophy of soft tissues and bones, and venous malformations of the extremities. Adenocarcinoma is a malignant formation of the glandular epithelium. This disease is extremely rare in children (about 1 case per 1 million people under the age of 20 years annually) due to its large regenerative potential and the absence of comorbid conditions that accumulate with age. In the article, we presented a case demonstrating a combination of these rare and severe diseases in a child. Case Report . We present a case report of the manifestation of adenocarcinoma of the transverse colon with the development of an acute intestinal obstruction clinic in a child with KTS. Conclusion . This case report demonstrates the combination of KTS and moderately malignant transverse colon adenocarcinoma in a child. This case is unique and valuable for clinical practice, emphasizing the need for thorough examination of patients with KTS due to the risk of cancer due to mutations in the PIK3CA oncogene. The combination of KTS with aggressive carcinoma leads to the development of complex comorbid pathology. The mutual aggravation of these diseases critically limits the possibilities of therapeutic correction and, as a result, dramatically reduces the expected survival rate of such patients.
- 17 October 2024
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 10,p. 1252-1261
Intensive care of intracranial hemorrhages in infants: а 5-year single-center experience
Introduction: Prevention of hemorrhagic disease in newborns (HDN) in recent years has significantly reduced the number of intracranial hemorrhages (ICH) associated with these pathologies and the most common etiological cause of hemorrhagic stroke in infants. However, the issues of intensive therapy for intracranial hemorrhages in young patients of various etiologies didn’t lose their relevance.Objective: Study of the peculiarities of approaches to intensive care in children with ICH. Material and methods: The medical documentation of 35 patients aged 21 days to 4 months with ICH of various etiologies from 2017 to 2021 was analyzed. Results: Due to the severity of their conditions, 83 % of patients required mechanical ventilation. In our case series of 29 children with vitamin K-deficient coagulopathy the mortality was 3.4 %. Cerebral vasospasm developed in 57.1 % of intracranial hemorrhage cases. The duration of stay in the intensive care unit and the duration of mechanical ventilation, in addition to the severity of the condition at admission, hemorrhagic shock and neurological deficit, were influenced by cerebral vasospasm and convulsive syndrome. Conclusion: A retrospective analysis of the results of the treatment of neonates with intracranial hemorrhages caused by a late form of HDN allowed us to identify factors affecting the severity of the condition and outcomes. Since the incidence of this severe pathology is relatively low, and the literature data are contradictory, the personal experience of each hospital is important.
- 17 October 2024
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 10,p. 1252-1261
Intensive care of intracranial hemorrhages in infants: а 5-year single-center experience
Introduction: Prevention of hemorrhagic disease in newborns (HDN) in recent years has significantly reduced the number of intracranial hemorrhages (ICH) associated with these pathologies and the most common etiological cause of hemorrhagic stroke in infants. However, the issues of intensive therapy for intracranial hemorrhages in young patients of various etiologies didn’t lose their relevance.Objective: Study of the peculiarities of approaches to intensive care in children with ICH. Material and methods: The medical documentation of 35 patients aged 21 days to 4 months with ICH of various etiologies from 2017 to 2021 was analyzed. Results: Due to the severity of their conditions, 83 % of patients required mechanical ventilation. In our case series of 29 children with vitamin K-deficient coagulopathy the mortality was 3.4 %. Cerebral vasospasm developed in 57.1 % of intracranial hemorrhage cases. The duration of stay in the intensive care unit and the duration of mechanical ventilation, in addition to the severity of the condition at admission, hemorrhagic shock and neurological deficit, were influenced by cerebral vasospasm and convulsive syndrome. Conclusion: A retrospective analysis of the results of the treatment of neonates with intracranial hemorrhages caused by a late form of HDN allowed us to identify factors affecting the severity of the condition and outcomes. Since the incidence of this severe pathology is relatively low, and the literature data are contradictory, the personal experience of each hospital is important.
- 3 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 2
Prevention of thrombotic complications in critically ill children
Background. Thrombotic complications are common in critically ill children requiring prolonged intensive care. Identification of risk factors of thrombosis with simultaneous assessment of the likelihood of hemorrhagic complications underlies decision making on prevention of hypercoagulation. However, there are currently no clear recommendations and schemes of anticoagulation for certain diseases. Objective. To analyze risk factors, current methods of prevention and treatment of thrombotic complications in critically ill children. Material and methods. We analyzed 65 articles in the PubMed and Russian Science Citation Index databases between 2017 and 2022. The following keywords were used: «thromboprophylaxis», «thromboembolism», «intensive care unit», «critical care», «pediatric», «thrombosis in children», «thromboprophylaxis in children». Results. The main risk factors of thrombotic complications in children are age up to one year and severe diseases requiring long-term immobilization and accompanied by coagulopathy. Conclusion. The main method of preventing thrombotic complications in children is the earliest possible motor activity of ICU patients. The most effective drugs are high and low molecular weight heparins, although there is currently no clear opinion.
- 3 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 2
Prevention of thrombotic complications in critically ill children
Background. Thrombotic complications are common in critically ill children requiring prolonged intensive care. Identification of risk factors of thrombosis with simultaneous assessment of the likelihood of hemorrhagic complications underlies decision making on prevention of hypercoagulation. However, there are currently no clear recommendations and schemes of anticoagulation for certain diseases. Objective. To analyze risk factors, current methods of prevention and treatment of thrombotic complications in critically ill children. Material and methods. We analyzed 65 articles in the PubMed and Russian Science Citation Index databases between 2017 and 2022. The following keywords were used: «thromboprophylaxis», «thromboembolism», «intensive care unit», «critical care», «pediatric», «thrombosis in children», «thromboprophylaxis in children». Results. The main risk factors of thrombotic complications in children are age up to one year and severe diseases requiring long-term immobilization and accompanied by coagulopathy. Conclusion. The main method of preventing thrombotic complications in children is the earliest possible motor activity of ICU patients. The most effective drugs are high and low molecular weight heparins, although there is currently no clear opinion.
- 10 December 2019
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 98 (6)
HOMOCYSTINURIA AS A RARE CAUSE OF PANCREATITIS IN CHILDREN
Облако Mail.ru - это ваше персональное надежное хранилище в интернете.
- 10 December 2019
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 98 (6)
HOMOCYSTINURIA AS A RARE CAUSE OF PANCREATITIS IN CHILDREN
Облако Mail.ru - это ваше персональное надежное хранилище в интернете.